Medical network - on February 21, the New Year's bell is still lingering in the ear, Chinese herbal medicine market in 2017 opened in the firecrackers. Drug market after 2016 rose, how to find the drug market business opportunities in 2017?
Three price cycle
Increase in the price of the third round of cycle, the rich variety of commodities rise, than the first two rounds of cycle, and the first record of varieties more
Chinese herbal medicine market since its opening, has experienced several big cycle changes, small period of 5 years, large cycle takes 10 years.
The first price cycle began in 1988. The soaring price cycle breed is not much, only the dogwood rose to 200 yuan of above, and the price, notoginseng topped 300 yuan (120). Other materials than before also rose slightly, relative to the price level at that time, the increase is not small, but prices if the variety ratio of stars.
The second round of price increases cycle occurred in 1998, in 2001. The price cycle appeared many dark horse breeds, such as: bergamot 35 yuan, from 1997 to 1998 years in September has gradually rose to 150 yuan of above, enter in September, 2000, jumped to 2000 yuan; In medicinal materials and anise, 35 yuan started from 2000, to March 2001 reach one hundred yuan, and the price; Forsythia from long-term 7 yuan prices rose to 18 ~ 19 yuan. Mountain cornus since prices fell behind in the first round, 20 yuan, from 1998 to 2000 in 340 yuan of above. Other price increases of medicinal materials and dangshen, Chinese angelica, safflower, etc varieties.
The third round of price increases cycle until 2009. It is this year, set off later drug market full wave red, rise in price of the medicinal material emerge in endlessly. Gain a larger varieties: notoginseng rose to 800 yuan of above; Platycodon grandiflorum gradeless and uniformly priced goods prices rose to 85 yuan; Dangshen gradeless and uniformly priced goods prices also crossed one hundred yuan; Angelica prices rose to 60 yuan; Rhizoma ligustici wallichii prices rose to 34 ~ 35 yuan. Atractylodes prices over 40 yuan. Radix isatidis jumped from 5 ~ 6 yuan to 30 yuan; Yuan hu prices rose to 80 yuan of above; Prince CanTong goods rose to 370-370 yuan. Rhizoma coptidis in early 1998, the price is in 26 yuan wander up and down, prices have risen in March, 2000, 110 yuan of above, to September price has exceeded 200 yuan, and the price; In the first half of 2009 dwarf lilyturf gradeless and uniformly priced goods prices are in RMB 20 (sichuan) floating up and down, until April 2011 has soared to 2011 yuan, created for ever; Fructus arctii prices also rose to 38 yuan. Angelica, radix scrophulariae, alisma, windproof, coastal glehnia root, radix trichosanthis, water pinellia, rhizoma arisaematis, rhizoma anemarrhenae, phlegm, angelica dahurica, poria cocos, gastrodia elata, milkvetch seed, honeysuckle, common cnidium fruit, sophora japonica, leeches in the different amplitude increases. Many wild medicinal herbs are also increase prices, such as: building, hyacinth bletilla, grifola, golden cicada, cat's claw, rhizoma atractylodis, radix paeoniae rubra, cortex dictamni, etc.
Increase in the price of the third round of cycle, the rich variety of commodities to rise, the first two rounds of cycle can be compared, and the first record of varieties more. This is of a variety of factors, the main reason is that sufficient liquidity. After 30 years of reform and opening up in China, especially the past more than ten years of development, national income rise generally, drug companies after years of struggle and accumulate a lot of money, so as to seek investment opportunities in the pharmaceutical affairs. Increase in the price of the third round of cycle was broke out in so many medicinal herbs, is a large number of hot Qian Qi to the role.
Drug market opportunity lies
Natural disasters are set off three rounds of drug market price "fuse", in 2017 the more uncertain factors still exist in drug market. Increase in the price of according to the first three rounds cycle inference, continue for at least 2 ~ 3 years. Drug market lies the greater business opportunities in the future
Reviews drug market experience three price cycle, it is not difficult to find that one of the common factor - a natural disaster. Price whether it is the first cycle of cornus, or a second round of price increases cycle the soaring price of bergamot, star anise, and the third round of price of notoginseng, pseudostellaria root, dangshen, Chinese angelica, etc., all related to natural disasters. Can be said to be the natural disasters are set off three rounds of drug market price "fuse", then, in 2017 drug market opportunities in where?
For drug market trend in 2017, many traders said worries, because most medicinal materials prices have risen by 2016, farmers income is good, the drug fever again in various medicinal origin in full swing. Actually, according to the drug market cycle "up for three years, three years, not rise not fall again three years", the fourth round of price increases cycle should be coming in 2018. Most medicinal materials prices rose early in 2016, adumbrative this round of price increases cycle on the vine due? The price of 2016 varieties, did not increase the third cycle, most of the medicinal materials prices did not rise to cycle on the price. For example: the third cycle limit price rose to 40 yuan of above, the price is not up to 28 yuan. Angelica dahurica prices during the previous cycle gradeless and uniformly priced goods prices rose to $16 ~ 17, and this time gradeless and uniformly priced goods prices only rise to 9 yuan; And radix scutellariae, windproof, coastal glehnia root, radix platycodi, radix scrophulariae and rhizoma chuanxiong, rhizoma alismatis, gold sand, radix curcumae, fructus arctii, white sea, phlegm, chrysanthemum, honeysuckle, etc., before more than the price did not catch up with the wheel.
In fact, most of the 2016 medicinal materials prices continue to wandered the trough for a year, if the afternoon will be pregnant with greater business opportunities. If, for example, atractylodes continues to run up and down in 12 yuan by the end of 2016, not only discourage herbalist planting, and breeding bases will be less serious phenomenon of lack of seedlings, want to cultivate, then may buy more of the seedlings, followed by the city how much price space is hard to imagine. Platycodon grandiflorum, and if it is not a year ahead of price increases, one hundred yuan, and the price is really is not a dream. Does this mean that the drug market opportunities difficult again in 2017? Increase in the price of according to the first three rounds cycle inference, continue for at least 2 ~ 3 years. If 2017 drug market really calm, don't be pessimistic, the broad masses of manufacturers and drug market lies the greater business opportunities in the future. Things are always in the continuous development of transformation, in 2017 the more uncertain factors still exist in drug market.
1 the national policy vigorously support traditional Chinese medicine, much better and brighter future drug market prospects.
A series of positive policy has brought Chinese medicine in 2016 spring. Traditional Chinese medicine into the national "much starker choices-and graver consequences-in planning outline", the state council has launched the development strategy of traditional Chinese medicine outline (2016-2030) ", by 2020 everyone enjoy basic medical services, Chinese traditional medicine and Chinese medicine yinpian incorporated into the scope of coverage. So, there is an upward trend in Chinese medicine raw materials demand, excess of Chinese herbal medicine raw materials will be effective to digest. Demand is the absolute principle, as long as there is demand for medicinal materials prices wouldn't have dropped sharply. Policy, will tend to support the medicinal material to a sharp drop in price, even some herbs in the market demand led by rose.
2 high quality Chinese prices expected to rise further.
After new "pharmacopoeia" enacted in 2015, medical unit pay more attention to quality, heavy metals, pesticide residues, sulphur excessive amounts of medicinal materials will be rejected, and reach the standard of "pharmacopoeia of the medicinal materials will get the favour of medicine unit, its price is higher than that of natural unqualified medicinal materials. Such as: the price of fritillaria thunbergiiwere sulphur-free 85 yuan, and the price of sulfur to sell about 80 yuan; Sweet chrysanthemum, 36 and 37 yuan price, sulfur-containing goods price is only 20 yuan; Sweet root of herbaceous peony and sulfur goods price is 2 ~ 3 yuan. More effective content affect the price of medicine, such as: fructus viticis. Jiangxi to produce authentic content standard gradeless and uniformly priced goods sold 150 yuan, and the content of lower import prices up and down in 12.5 yuan.
Chinese medicinal materials quality has influence to the price, the future will be more medicine price distance caused by quality problems, quality authentic medicinal materials prices expected to rise further.
3 as a food and medicine health care drugs price to continue to improve.
This century will be a big health industry has had tremendous development of era, more and more people pay attention to health care, and as a food and as medicine of traditional Chinese medicine raw materials will continue to increase, such as: dangshen, Chinese angelica, barbary wolfberry fruit, cassia seed, honeysuckle, rhizoma polygonati, ginseng, American ginseng, Chinese yam, hawthorn, ebony, jade bamboo, lily, coix seed, etc.
With the increasing sales of these herbs, its future market is expected to continue to improve, and even some varieties can hit a record high. In 2017 as a food and medicine herbs will continue to be popular, do not rule out a few varieties prices also rose.
Four natural disasters is still a prelude to detonate medicinal materials rise in price.
Over the past few years, the high temperature, drought, sounds, flooding, pollen... O., get drug market prices were surging, 2017 drug market prices still certain medicinal materials prices caused by natural disasters. Flowers, fruit varieties of medicinal materials is the influence of pollen in spring, while the root-stock medicinal materials are susceptible to drought and rainy weather, should pay close attention to the different seasonal weather change, maybe it in which business opportunities.
5 drug market is expected to thrive in the future.
Discussed in early 2016 the state council Wednesday presided by the strategic plan for development of Chinese medicine (2016-2030), by 2020, everyone enjoys the basic services of traditional Chinese medicine, Chinese medicine gross industrial output value accounted for over 30% of the pharmaceutical industry output value; By 2030, services to achieve full coverage of traditional Chinese medicine, basic formed by hundreds of national physician, master teacher, millions of TCM doctor of traditional Chinese medicine, Chinese medicine personnel of tens of millions of professional skill personnel.
The policy for traditional Chinese medicine is a big positive, sales of Chinese herbal medicine will swell, the vigorously support of national policy, and with great health, the arrival of the era of large pharmaceutical, inject new vitality to the drug market, promote drug market recovery ahead of the downturn, gradually to prosperity.
Conclusion > > >
2017 drug market is difficult to reproduce the hot streak of blossoming, because most of the medicinal material prices has risen in the past year step, and medicinal material production are not really large scale down, but does not rule out a few varieties of a good and big business opportunities. So, don't need to drug market too pessimistic about the future, from the big trend analysis, drug market really rally cycle has not arrived, rise in price is still on the way. |
